Lncap
Lncap - Related Videos
09:45
Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
0 Views •
2025
Circulating tumor cells (CTCs) are critical for the study of cancer progression and metastasis. This article presents a high-throughput, integrated protocol for CTC enrichment and single-CTC sequencing, improving capture efficiency and CTC purity while reducing contamination and sequencing costs, thereby advancing precision oncology research and clinical applications.
02:39
An In Vivo PET Imaging Technique to Detect Tumors in a Murine Model Using Radiolabeled Antibodies
0 Views •
2025
This video demonstrates a technique involving a radioimmunoconjugate for the in vivo imaging of a tumor in a mouse model. Upon injection of the radioimmunoconjugate, the antibodies of the conjugate bind to a specific membrane antigen on the cancer cells. The radiotracer of the conjugate emits positrons that interact with neighboring electrons to produce energy, which is detected by a positron emission tomography (PET) scanner to create an image of the tumor.
FAQs
Androgen binding to the functional receptor activates transcription of androgen-responsive genes, linking a molecular signal to measurable changes in the cells. This signaling can promote cellular growth and stimulate production of prostate-specific antigen, or PSA. Consequently, LNCaP experiments can examine how androgen exposure influences both prostate-specific gene regulation and cancer-related cell behavior.
The altered receptor can change how LNCaP cells respond to particular steroid hormones and therapeutic compounds. This feature allows researchers to investigate responses that may differ from those produced by an unaltered receptor, while also requiring careful interpretation of treatment results. It is especially relevant to studies of hormone signaling, drug activity, and therapeutic resistance.
PSA production provides a measurable indicator of androgen-responsive gene activity in LNCaP cells. When androgen signaling activates transcription, changes in PSA can help researchers assess whether the pathway is functioning and how strongly it responds. Used alongside cellular growth measurements, PSA offers a molecular readout for connecting receptor activity with broader prostate cancer behavior.
LNCaP cells allow investigators to examine several connected outcomes within one androgen-responsive model: receptor-mediated transcription, prostate-specific gene regulation, cellular growth, and responses to treatment. Studying these outcomes together helps clarify how molecular signaling may contribute to androgen-dependent tumor progression. The model therefore supports research that moves from pathway activity toward cancer-relevant cellular behavior.
The model supports laboratory investigations of androgen-dependent tumor progression, prostate-specific gene regulation, therapeutic resistance, and anticancer drug effects. Researchers can focus on how androgen signaling changes transcription or growth, or assess how treatments alter those responses. Its reproducible growth and hormone responsiveness make comparisons across related experiments more practical and interpretable.
Investigators can evaluate how anticancer compounds affect LNCaP growth and hormone-responsive behavior, then consider those effects in relation to the cells’ altered receptor. Such studies may reveal whether a treatment influences androgen-linked processes or produces responses associated with therapeutic resistance. The system is therefore useful for connecting drug effects with prostate cancer biology rather than measuring treatment activity alone.